
Galapagos NV (GLPGA) | Financial Analysis & Statements
Galapagos NV | Large-cap | Healthcare
Galapagos NV | Large-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
65.3M
Gross Profit
60.6M
92.79%
Operating Income
-57.0M
-87.35%
Net Income
-105.7M
-161.97%
Balance Sheet Metrics
Total Assets
4.0B
Total Liabilities
1.3B
Shareholders Equity
2.7B
Debt to Equity
0.46
Cash Flow Metrics
Operating Cash Flow
-43.0M
Free Cash Flow
-43.9M
Revenue & Profitability Trend
Galapagos NV Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 275.6M | 239.7M | 241.2M | 234.4M | 478.1M |
Cost of Goods Sold | 34.9M | - | 12.1M | 1.6M | 0 |
Gross Profit | 240.8M | - | 493.2M | 483.2M | 478.1M |
Gross Margin % | 87.4% | 0.0% | 204.4% | 206.2% | 100.0% |
Operating Expenses | |||||
Research & Development | 335.5M | 241.3M | 269.8M | 320.5M | 523.7M |
Selling, General & Administrative | 96.9M | 94.3M | 103.3M | 89.2M | 158.0M |
Other Operating Expenses | -16.4M | -23.6M | -9.4M | -20.2M | -30.3M |
Total Operating Expenses | 416.0M | 311.9M | 363.7M | 389.6M | 651.4M |
Operating Income | -188.3M | -88.3M | -131.1M | -171.6M | -178.6M |
Operating Margin % | -68.3% | -36.8% | -54.3% | -73.2% | -37.4% |
Non-Operating Items | |||||
Interest Income | 89.8M | 79.6M | 18.1M | 2.9M | 10.0M |
Interest Expense | 911.0K | 1.8M | 9.2M | 11.6M | 9.4M |
Other Non-Operating Income | 95.8M | 16.3M | 51.5M | 61.5M | -116.3M |
Pre-tax Income | -3.1M | 5.6M | -70.8M | -119.4M | -309.8M |
Income Tax | -1.8M | 9.6M | 572.0K | 1.4M | 1.2M |
Effective Tax Rate % | 0.0% | 170.9% | 0.0% | 0.0% | 0.0% |
Net Income | 74.1M | 211.7M | -218.0M | -103.2M | -305.4M |
Net Margin % | 26.9% | 88.3% | -90.4% | -44.0% | -63.9% |
Key Metrics | |||||
EBITDA | -52.5M | 34.8M | -47.6M | -134.6M | -165.4M |
EPS (Basic) | €1.12 | €3.21 | €-3.32 | €-1.58 | €-4.69 |
EPS (Diluted) | €1.12 | €3.21 | €-3.32 | €-1.58 | €-4.69 |
Basic Shares Outstanding | 66144643 | 65884000 | 65659940 | 65500000 | 65075000 |
Diluted Shares Outstanding | 66144643 | 65884000 | 65659940 | 65500000 | 65075000 |
Income Statement Trend
Galapagos NV Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 64.2M | 166.8M | 508.1M | 2.2B | 2.1B |
Short-term Investments | 3.1B | 3.5B | 3.6B | 2.5B | 3.0B |
Accounts Receivable | 32.5M | 17.5M | 28.2M | 91.8M | 134.6M |
Inventory | 51.2M | 74.0M | 52.9M | 20.6M | 355.0K |
Other Current Assets | - | - | 2.0K | -1.0K | - |
Total Current Assets | 3.3B | 3.9B | 4.2B | 4.9B | 5.4B |
Non-Current Assets | |||||
Property, Plant & Equipment | 8.6M | 6.8M | 11.6M | 60.3M | 37.3M |
Goodwill | 304.9M | 267.0M | 286.0M | 60.1M | 67.6M |
Intangible Assets | 164.9M | 127.9M | 146.4M | 60.1M | 67.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 179.9M | 148.2M | 127.1M | 133.7M | 168.5M |
Total Non-Current Assets | 796.3M | 495.8M | 497.5M | 331.3M | 348.4M |
Total Assets | 4.1B | 4.4B | 4.7B | 5.2B | 5.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 97.8M | 134.7M | 133.3M | 134.3M | 171.3M |
Short-term Debt | 3.5M | 4.7M | 7.2M | 7.2M | 6.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 5.0K | 32.0M | 8.5M | 204.0K | 12.1M |
Total Current Liabilities | 335.1M | 428.2M | 522.5M | 566.5M | 635.3M |
Non-Current Liabilities | |||||
Long-term Debt | 8.2M | 4.9M | 14.7M | 19.7M | 23.0M |
Deferred Tax Liabilities | 20.7M | 23.6M | 20.1M | 0 | 0 |
Other Non-Current Liabilities | 33.8M | 31.6M | 21.8M | 7.1M | 8.1M |
Total Non-Current Liabilities | 903.7M | 1.1B | 1.7B | 2.0B | 2.4B |
Total Liabilities | 1.2B | 1.6B | 2.2B | 2.5B | 3.0B |
Equity | |||||
Common Stock | 293.9M | 293.9M | 293.6M | 292.1M | 291.3M |
Retained Earnings | -134.3M | -228.3M | -496.7M | -367.2M | -334.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.9B | 2.8B | 2.5B | 2.6B | 2.7B |
Key Metrics | |||||
Total Debt | 11.7M | 9.6M | 21.9M | 26.9M | 29.4M |
Working Capital | 3.0B | 3.4B | 3.7B | 4.3B | 4.7B |
Balance Sheet Composition
Galapagos NV Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 74.1M | 211.7M | -218.0M | -103.2M | -305.4M |
Depreciation & Amortization | 45.5M | 43.6M | 65.6M | 34.6M | 18.7M |
Stock-Based Compensation | 19.9M | 56.7M | 88.5M | 70.7M | 80.0M |
Working Capital Changes | -320.6M | -692.4M | -351.3M | -430.4M | -353.9M |
Operating Cash Flow | -300.6M | -460.4M | -439.5M | -407.1M | -542.3M |
Investing Activities | |||||
Capital Expenditures | -16.7M | -16.3M | -26.6M | -54.2M | -42.5M |
Acquisitions | -8.9M | -7.0M | -115.3M | 28.7M | 0 |
Investment Purchases | -3.4B | -3.4B | -2.7B | -1.6B | -4.6B |
Investment Sales | 3.7B | 3.5B | 1.6B | 2.1B | 5.4B |
Investing Cash Flow | 256.5M | 57.0M | -1.2B | 544.9M | 802.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -4.9M | -6.8M | -8.2M | -7.2M | -6.2M |
Financing Cash Flow | -4.9M | -5.0M | -1.5M | -3.9M | 22.0M |
Free Cash Flow | -402.1M | -425.2M | -537.5M | -561.7M | -518.7M |
Net Change in Cash | -49.0M | -408.4M | -1.7B | 133.9M | 282.4M |
Cash Flow Trend
Galapagos NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
51.71
Forward P/E
-41.14
Price to Book
0.72
Price to Sales
6.89
PEG Ratio
-41.14
Profitability Ratios
Profit Margin
-103.14%
Operating Margin
-87.35%
Return on Equity
-10.39%
Return on Assets
-5.11%
Financial Health
Current Ratio
8.08
Debt to Equity
0.32
Beta
0.03
Per Share Data
EPS (TTM)
€-4.38
Book Value per Share
€40.12
Revenue per Share
€4.18
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
glpga | 1.9B | 51.71 | 0.72 | -10.39% | -103.14% | 0.32 |
Pharming Group N.V | 841.3M | 57.15 | 3.45 | -3.70% | -2.41% | 53.57 |
Vivoryon | 43.5M | -2.07 | 13.87 | -145.47% | 0.00% | 2.26 |
Koninklijke Philips | 22.7B | 150.00 | 2.20 | 1.51% | 0.91% | 80.96 |
ASML Holding N.V | 328.6B | 33.71 | 17.83 | 58.25% | 29.27% | 21.00 |
Shell plc | 181.5B | 15.96 | 1.00 | 7.54% | 5.00% | 41.33 |
Financial data is updated regularly. All figures are in the company's reporting currency.